BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 9241710)

  • 1. Familial thrombophilia: a complex genetic disorder.
    Koeleman BP; Reitsma PH; Bertina RM
    Semin Hematol; 1997 Jul; 34(3):256-64. PubMed ID: 9241710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual genetic abnormality in the coagulation pathway as a cause of familial thrombophilia.
    Khaira A; Kalra OP; Gupta A; Khaira DD
    J Assoc Physicians India; 2009 Jul; 57():529-30. PubMed ID: 20329415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
    van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
    Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inherited basis of venous thrombosis.
    Appleby RD; Olds RJ
    Pathology; 1997 Nov; 29(4):341-7. PubMed ID: 9423212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial thrombosis and the role of thrombophilia.
    Boekholdt SM; Kramer MH
    Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial thrombophilia is an oligogenetic disease: involvement of the prothrombin G20210A, PROC and PROS gene mutations.
    Boinot C; Borgel D; Kitzis A; Guicheteau M; Aiach M; Alhenc-Gelas M
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):191-6. PubMed ID: 12632031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary protein S deficiency and familial thrombosis. A review with description of a Danish family with protein S deficiency].
    Ingerslev J; Ingerslev J; Thelle T
    Ugeskr Laeger; 1993 May; 155(22):1703-7. PubMed ID: 8317013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance to activated protein C disclosed by postphlebitic disease. Two cases].
    Foueré S; Lestang P; Cosnes A; Gouault-Heilmann M; Revuz J
    Ann Dermatol Venereol; 1996; 123(1):24-5. PubMed ID: 8734112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
    Finazzi G; Barbui T
    Thromb Haemost; 1994 Jan; 71(1):15-8. PubMed ID: 8165635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindred.
    Scott BT; Bovill EG; Callas PW; Hasstedt SJ; Leppert MF; Valliere JE; Varvil TS; Long GL
    Thromb Haemost; 2001 Jan; 85(1):82-7. PubMed ID: 11204593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A laboratory approach to the evaluation of hereditary hypercoagulability.
    Adcock DM; Fink L; Marlar RA
    Am J Clin Pathol; 1997 Oct; 108(4):434-49. PubMed ID: 9322598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
    Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited prethrombotic disorders and infectious purpura.
    Westendorp RG; Reitsma PH; Bertina RM
    Thromb Haemost; 1996 Jun; 75(6):899-901. PubMed ID: 8822583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.